4D pharma plc (LON:DDDD – Get Rating)'s share price was up 5% during trading on Tuesday . The stock traded as high as GBX 16.86 ($0.20) and last traded at GBX 16.66 ($0.20). Approximately 912,370 shares were traded during mid-day trading, a decline of 69% from the average daily volume of 2,957,490 shares. The stock had previously closed at GBX 15.86 ($0.19).
4D pharma Stock Up 5.0 %
The company has a quick ratio of 4.72, a current ratio of 5.21 and a debt-to-equity ratio of 39.50. The company has a fifty day simple moving average of GBX 16.66 and a 200 day simple moving average of GBX 28.63. The firm has a market capitalization of £30.04 million and a P/E ratio of -1.08.
About 4D pharma
(Get Rating)
4D pharma plc, together with its subsidiaries, develops live biotherapeutic products (LBPs) in the United Kingdom. The company develops therapeutic candidates, including MRx0518 for the treatment of cancer and immune-oncology diseases; MRx-4DP0004 for the treatment of asthma; MRx0029 and MRx0005 the treatment of central nervous system disorders; Blautix for irritable bowel syndrome; and Thetanix for pediatric crohn's disease.
Further Reading
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle's FQ1 Report
- Three Value Stocks For A Volatile Market
- 3 Energy Stocks Nearing Breakouts From Cup-Shaped Patterns
- Do These Dividend Achievers Deserve A Place In Your Portfolio?
Receive News & Ratings for 4D pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 4D pharma and related companies with MarketBeat.com's FREE daily email newsletter.